Shows
Evidence-Based GI: An ACG Publication and PodcastICYMI: Lynch Syndrome-An Aspirin a Day Keeps Colorectal Cancer Away!Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swati Patel, MD, MS discuss “Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial,” by Burn J, Sheth H, Elliot F, et al. Lancet 2020;395:1855-63.2023-12-1310 minEvidence-Based GI: An ACG Publication and PodcastLong Road to Achieving Competence in Cold Snare Polypectomy: Video-Based Feedback Can Help!Philip Schoenfeld, MD, MSEd, MSc (Epi) and Swati Patel, MD, MS discuss “Varied Trainee Competence in Cold Snare Polypectomy - Results of the COMPLETE Randomized Controlled Trial,” by Kaltenbach T, Patel SG, Nguyen-Vu T, Malvar C, Keswani RN, Hall M, Aagaard E, Asokkumar R, Chin YK, Hammad H, Rastogi A, Shergill A, Simon V, Soetikno A, Soetikno R, Wani S. Am J Gastroenterol. [2023 Jun 13].2023-09-1316 min
Research To Practice | Oncology VideosGastroesophageal and Hepatobiliary Cancers | Cases from the Community: Investigators Discuss Available Research Guiding the Care of Patients with Gastroesophageal and Hepatobiliary Cancers — A 2023 Post-ASCO GI WebcastFeaturing perspectives from Drs Eric Lee, Neil Morganstein and Swati Vishwanathan, including the following topics: • Gastroesophageal Cancers — Zev Wainberg, MD, MSc o Introduction (0:00) o Systemic therapy considerations for HER2-negative localized gastroesophageal cancers (4:33) o First-line systemic therapy for metastatic esophageal or gastric cancer (10:05) o Zolbetuximab/chemotherapy as first-line treatment for HER2-negative, locally advanced unresectable or metastatic gastric and gastroesophageal junction cancers (16:19) o Repeat tissue biopsy versus circulating tumor DNA testing for HER2-positive GI cancers after disease progression on first-line therapy (20:59) o Trastuzumab deruxtecan as second-line therapy...2023-04-041h 00